Amorphous Solid Dispersions

1 Fundamentals of Amorphous Systems: Thermodynamic Aspects.- 2 Theoretical Considerations in Developing Amorphous Solid Dispersions.- 3 Overview of Amorphous Solid Dispersion Technologies.- 4 Excipients for Amorphous Solid Dispersions.- 5 Miniaturized Screening Tools for Polymer and Process Evaluation.- 6 HME for Solid Dispersions: Composition and Design Considerations.- 7 HME for Solid Dispersions: Scale up and Late Stage Development.- 8 Spray Drying: Scale UP and Manufacturing.- 9 Design and Development of HPMCAS based spray dried dispersions.- 10 MBP Technology: Composition and Design Considerations.- 11 MBP Technology: Process Development and Scale up.- 12 Pharmaceutical Development of MBP Solid Dispersions: Case Studies.- 13 Downstream Processing Considerations.- 14 Structural Characterization of Amorphous Solid Dispersions.- 15 Dissolution of Amorphous Solid Dispersions: Theory and Practice.- 16 Stability of Amorphous Solid Dispersion.- 17 Regulatory Considerations in Development of Amorphous Solid Dispersions.- 18 KinetiSol® based Amorphous Solid Dispersions.- 19 Amorphous Solid Dispersion Using Supercritical Fluid Technology.- 20 Supersolubilization by Using Non-Salt Forming Acid-Base Interaction.- 21 Stabilized Amorphous Solid Dispersions with Small Molecule Excipients.- 22 Mesoporous ASD - Fundamentals.- 23 Mesoporous Silica Drug Delivery Systems.

Navnit Shah : President and CSO, Kashiv Pharma LLC, Piscatway, NJ 08854 Harpreet Sandhu: Senior Research Leader, Hoffmann La Roche Inc, Nutley, NJ Duk soon Choi : Senior Research Leader,Hoffmann La Rroche Inc, Nutley, NJ Hitesh Chokshi: Senior Research Director, Hoffmann La Roche Inc, Nutley, NJ Waseem Malick : Vice President R&D, Hoffmann La Roche Inc, Nutley, NJ.